Clinical Trial Update: Zonisamide for the Treatment of Obstructive Sleep Apnea in Overweight/Obese Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating zonisamide for obstructive sleep apnea in overweight/obese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Obstructive Sleep Apnea

Drugs mentioned

• Zonisamide (Zonegran) (zonisamide)

Snippet

Sponsor: Göteborg University | Conditions: Sleep Apnea, Obstructive Sleep Apnea | Phase 2 | Status: COMPLETED